Text Size
50 studies found for:    Open Studies | "heart transplantation"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Autonomic Cardiovascular Control After Heart Transplantation
Condition: Heart Transplant Recipients
Intervention:
2 Not yet recruiting Pharmacology of Immunosuppressants Following Heart Transplantation
Condition: Heart Transplantation
Intervention:
3 Unknown † Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation
Condition: H1N1 Influenza
Intervention:
4 Recruiting Outcomes AlloMap Registry: the Long-term Management and Outcomes of Heart Transplant Recipients With AlloMap Testing
Conditions: Cardiac Transplant Failure;   Cardiac Transplant Rejection;   Heart Diseases
Intervention:
5 Recruiting Genetic Predictors of Renal Dysfunction Following Heart Transplantation
Conditions: Heart Transplantation;   Chronic Renal Insufficiency
Intervention:
6 Recruiting Heartsbreath Test for Heart Transplant Rejection
Condition: Heart Transplant Rejection
Intervention:
7 Not yet recruiting Home Electrocardiogram (ECG) Monitoring After Heart Transplantation
Conditions: Cardiac Transplant Rejection;   Qt Interval, Variation in
Intervention:
8 Recruiting Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation
Conditions: Cardiac Allograft Vasculopathy;   Antibody Mediated Rejection
Interventions: Device: Optical Coherence Tomography;   Drug: Acetylcholine;   Procedure: Brachial Artery Flow Mediated Dilation
9 Recruiting High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia
Condition: Exercise Capacity
Interventions: Behavioral: High Intensity Interval Training;   Behavioral: Moderate Training
10 Recruiting Cardiac Magnetic Resonance Imaging (CMRI) for Detection of Cardiac Transplant Rejection
Condition: Heart Transplant Rejection
Intervention: Other: CARDIAC MRI
11 Recruiting Inhaled Nitric Oxide and Inhaled Prostacyclin After Cardiac Surgery for Heart Transplant or LVAD Placement
Condition: Heart Failure
Interventions: Drug: Nitric Oxide;   Drug: Prostacyclin
12 Recruiting A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Regimen Versus a Standard Regimen in de Novo Heart Transplant Recipients
Condition: Heart Transplantation
Interventions: Drug: MMF OR Myfortic, Certican®, Sandimmun® optoral;   Drug: Sandimmun Optoral, Certican
13 Unknown † Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant Patients
Condition: Heart Transplant
Intervention: Drug: cyclosporine, tacrolimus, mycophenolate mofetil and everolimus (immunosuppressive drugs)
14 Recruiting Scandinavian Heart Transplant de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance
Condition: Renal Function
Interventions: Drug: Everolimus;   Drug: Cyclosporine A
15 Recruiting Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation
Conditions: Hypertension;   Cardiac Transplantation
Intervention: Drug: Aliskiren
16 Recruiting Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
Conditions: Cardiac Allograft Vasculopathy;   Heart Transplant Recipients
Intervention:
17 Recruiting Allo-antibodies in Pediatric Heart Transplantation
Condition: Pediatric Heart Transplantation
Interventions: Drug: Induction Therapy (anti-T cell antibody induction);   Drug: Tacrolimus (Prograf);   Drug: Mycophenolate Mofetil- MMF (CellCept);   Procedure: Intraoperative plasma exchange/pheresis;   Procedure: Short-term post-operative plasmapheresis;   Drug: Post-transplant course of intravenous immunoglobulin (IVIG) therapy.;   Drug: Prednisone
18 Unknown † Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients
Conditions: Ischemia Reperfusion Injury;   Heart Transplantation
Interventions: Drug: Anti-Thymocyte Globulin;   Drug: Normal Saline
19 Recruiting CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial
Conditions: Cardiac Transplantation;   Skin Cancer
Intervention: Drug: Everolimus
20 Unknown † Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms
Condition: Heart Transplant Patients
Intervention: Drug: Myfortic
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years